Revised Overarching guideline on biosimilar

First Page		Document Content
Date: 2014-11-04 05:57:39 Research Pharmaceuticals policy Drug safety European Medicines Agency Biosimilar Biologic Pharmacovigilance Medicinal product Bioequivalence Pharmaceutical sciences Pharmacology Clinical research		Revised Overarching guideline on biosimilar Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 120,46 KB Share Document on Facebook

	16256000Basic information Name of medicinal product: …… Authorisation no: …… If known Application ID: …… If known DocID: 1xUPG - View Document
	MODsense TM An integrated and secure temperature monitoring solution. Qualified for monitoring medicinal product distribution. DocID: 1xU1W - View Document
	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of DocID: 1trcK - View Document
	Focus on Medicinal Products for Rare Diseases; Comparison of System in Japan with US and EU October 2011 In our August 2011 publication on the Japanese Orphan Medicinal Product Rules, we presented the system in Japan for DocID: 1soRp - View Document
	The format of this leaflet was determined by the Ministry of Health and its content was checked and approved by it. DOMITOR PACKAGE INSERT 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DOMITOR VETERINARY DocID: 1rWmz - View Document